Physiomics Plc
LSE: PYC.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Peter Joseph Sargent
- Employees
- 11
- Headquarters
- Oxford, United Kingdom
- IPO year
- 2004
- Market cap
- £1.8M
- Website
- https://www.physiomics.co.uk
Loading PYC…
Loading profile data…Frequently asked questions about PYC
What does Physiomics Plc (PYC.L) do?
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union. It offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its...
Where does PYC.L trade?
Physiomics Plc (PYC.L) trades on the London Stock Exchange.
What sector is PYC.L in?
Physiomics Plc (PYC.L) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Physiomics Plc?
Peter Joseph Sargent is the chief executive officer of Physiomics Plc (PYC.L).
Where is Physiomics Plc headquartered?
Physiomics Plc is headquartered in United Kingdom.
Does PYC.L pay a dividend?
Physiomics Plc (PYC.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PYC.L go public?
Physiomics Plc (PYC.L) completed its initial public offering in 2004.